期刊文献+

社区获得性败血症病原菌药敏试验结果分析 被引量:1

Analysis of drug sensitivity test on pathogenic bacteria of community-acquired septicemia
原文传递
导出
摘要 目的对社区获得性败血症的病原菌特点及药敏结果进行比较,为临床治疗提供依据。方法收集2009年1月-2010年12月43例败血症患者送检标本培养分离出的病原菌进行药敏试验分析。结果两年共检出病原菌43株,其中大肠埃希菌占30.2%、肺炎克雷伯菌占18.6%、表皮葡萄球菌占11.6%;大肠埃希菌对20种抗菌药物均存在不同程度的耐药,对氨苄西林、环丙沙星耐药率最高,均达84.1%,对阿米卡星敏感率为69.2%;肺炎克雷伯菌对哌拉西林/他唑巴坦、培氟沙星、加替沙星和氧氟沙星耐药率为0,耐药率最高为氨苄西林,达100.0%;表皮葡萄球菌对20种抗菌药物除哌拉西林/他唑巴坦、氯霉素外,对其他抗菌药物均有不同程度的耐药,耐药率最高为苯唑西林、氨苄西林、阿奇霉素、磺胺甲噁唑/甲氧苄啶,均为80.0%;对比两年大肠埃希菌、肺炎克雷伯菌、表皮葡萄球菌对抗菌药物的耐药率,差异均无统计学意义;2009年与2010年相比,社区获得性败血病的发病率、主要致病菌,差异均无统计学意义。结论医院2009年与2010年社区获得性败血症的主要病原菌构成、病原菌对抗菌药物的敏感性及发病率无明显变化。 OBJECTIVE To provide the basis for the treatment of community acquired septicemia in the future through comparing the pathogenic bacteria features and drug sensitivity results of the patients with community acquired septicemia. METHODS The drug sensitivity results of the pathogenic bacteria from 43 patients with septicemia were analyzed. RESULTS The main pathogens of septicemia were Escherichia coli(30.2%),Klebsiella pneumoniae(18.6%) and Staphylococcus epidermidis(11.6%).Escherichia coli came with varying degrees of drug resistance to the tested 20 kinds of antibiotics,whose drug resistance rate to ampicillin and ciprofloxacin could be up to 84.1%.And also its drug resistance rate to amikacin was maximally 69.2%.K.pneumoniae showed no drug resistance to piperacillin/tazobactam pefloxacin,gatifloxacin and ofloxacin,and its maximum drug resistance rate to ampicillin was 100.0%.Apart from piperacillin/taaopbactam and chloramphenicol of the 20 kinds of the tested antibiotics,Staphylococcus epidermidis came with varying degree of drug resistance to the other 18 kinds of antibiotics.Its maximum drug resistance was that to the oxacillin,ampicillin,azithromycin and compound sulfonamide(SMZ+TMP),which was 80.0%.Through analyzing and comparing the drug resistance rate of E.coli to the main antibiotics in recent two years,the differences were statistically insignificant.The difference of drug resistance rate of K.pneumoniae to the main drug resistant antibiotic had no statistical significance.And also the same is true of staphylococcus epidermidis.Through analyzing,the difference of incidence of community acquired septicemia between 2009 and 2010 was statistically insignificant.The same was true of the incidence of the main pathogenic bacteria for septicemia in the two years. CONCLUSION The susceptibility of the main pathogens causing community-acquired septicemia pathogens causing community-acquired septicemia has no significant change,and the incidence rate has no significant change as well.
作者 移军
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第22期4815-4817,共3页 Chinese Journal of Nosocomiology
关键词 社区获得性 病原菌 败血症 敏感性 Community-acquired Pathogenic bacteria Septicemia Sensitivity
  • 相关文献

参考文献3

二级参考文献11

  • 1宁宁,桂保松,姚钢炼,马力群,张星映,朱丹.甲磺酸帕珠沙星注射液治疗急性细菌感染52例[J].中国新药杂志,2005,14(9):1189-1192. 被引量:7
  • 2邵玉霞,鲍永霞,吕福祯.甲磺酸帕珠沙星治疗呼吸道细菌性感染的临床研究[J].中国新药杂志,2005,14(9):1195-1197. 被引量:3
  • 3施毅,肖永营,苏欣,邵海枫,宋勇,赵蓓蕾,曹鄂洪,肖鑫武,王卫萍,肖伟,王茂芬,孙丽华,章辉.注射用帕珠沙星治疗细菌性感染111例的临床随机对照研究[J].中国新药与临床杂志,2005,24(12):937-941. 被引量:18
  • 4张璟,孙自镛,马越,李景云,金少鸿.152株肺炎链球菌的耐药性及血清分型研究[J].中华医院感染学杂志,2007,17(4):468-471. 被引量:36
  • 5Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Eighteenth informational supplement. CIGI documents M100-S18. CLSI/NCCLS,2008.
  • 6Granger D, Boily-Larouche G, Turgeon P, et al. Molecular characteristics of pbpla and pbp2b in clinical Streptococcus pneurnoniae isolates in Quebec. Canada[J]. J Antimierob Chemoter,2006,57(1):61-70.
  • 7Schwaber MJ, Navon-Venezia S, Kaye KS, et al. Clinical and economic impact of bacteremia with extended-spectrum-β-lactamases-producing Enterobacteriaeeae[J]. Antimierob Agents Chemother, 2006,50(4) : 1257-1262.
  • 8Tumbarello M, Spanu T, Sanguinetti M, et al. Bloodstream infections caused by extended-spectrum-β-lactamases-producing Klebsiella pneumoniae :risk factors, molecular epidemiol- ogy and clinical outcome[J]. Antimicrob Agents Chemother, 2006,50(2):498 504.
  • 9Wang H, Kelkar S, Wu WY, etal. Clinical isolates of Enterobacteriaceae producing extended-spectrum β-lactamases:prevalence of CTX-M 3 at a hospital in China[J]. Antimicrob Agents Chemother, 2003,47(2) : 790-793.
  • 10Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically[S]. Seventh edition. Approved Standard. CLSI documents M7 A7. CLSI,2006.

共引文献306

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部